Skysis

Skysis was a U.S.-based boutique healthcare consulting firm focused on the biopharmaceutical industry rather than a drug-development biotech company. The company provided integrated market access and commercial strategy services, helping clients navigate payer, provider, channel, and patient dynamics. Its offerings appear to have centered on commercialization planning and market access strategy for biopharma products. Skysis was acquired by Fishawack Health in April 2020, and the Skysis brand was later retired as its team was absorbed into Avalere Health. As a result, it does not appear to operate today as an independent active company.